Allergan upgraded at William Blair6:28 AM EDT
AGN upgraded at William Blair. Rating raised to Outperform from Market Perform. Raises 2009 EPS estimates to $2.74 from $2.65.
Abercrombie & Fitch upgraded at Barclays6:51 AM EDT
ANF upgraded at Barclays. Rating raised to Overweight from Equal-weight. Price target raised to $35 from $22. 2009 EPS estimates raised to $0.89 from $0.81.
Burger King downgraded at JP Morgan6:21 AM EDT
BKC downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Price target lowered to $19 from $21. 2009 EPS estimates lowered to $1.36 from $1.38.
Genzyme downgraded at UBS6:39 AM EDT
GENZ downgraded at UBS. Rating lowered to Neutral from Buy. Price target lowered to $55 from $67. Maintains 2009 EPS estimates of $2.60.
Gap upgraded at Barclays6:50 AM EDT
GPS upgraded at Barclays. Rating raised to Overweight from Equal Weight. Price target raised to $21 from $18. 2009 EPS estimates raised to $1.26 from $1.25.
Ross Stores downgraded at Barclays6:48 AM EDT
ROST downgraded at Barclays. Rating lowered to Equal-weight from Overweight. Maintains $45 price target and 2009 EPS estimates of $2.83.
Wendys-Arbys Group upgraded at UBS6:40 AM EDT
WEN upgraded at UBS. Rating raised to Buy from Neutral. Price target raised to $5.50 from $4.90. Maintains 2009 EPS estimates of $0.18.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment